tempol has been researched along with Reperfusion Injury in 2 studies
*Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, L; Bi, W; Bi, Y; Gao, X; Itagaki, Y; Li, M; Li, X; Wang, Z; Xue, P; Zhang, Y | 1 |
| Bammert, C; Bi, L; Bi, W; Bi, Y; Gao, X; Hou, S; Jockusch, S; Legalley, TD; Li, P; Michael Gibson, K; Zhang, Y | 1 |
2 other study(ies) available for tempol and Reperfusion Injury
| Article | Year |
|---|---|
Novel TEMPO-PEG-RGDs conjugates remediate tissue damage induced by acute limb ischemia/reperfusion.
Topics: Animals; Cyclic N-Oxides; Free Radical Scavengers; Hindlimb; Histocytochemistry; Malondialdehyde; Muscle, Skeletal; Oligopeptides; Oxidative Stress; Platelet Aggregation; Polyethylene Glycols; Rats; Reperfusion Injury; Superoxide Dismutase | 2012 |
Indole-TEMPO conjugates alleviate ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Cyclic N-Oxides; Cytochromes c; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Intestine, Small; Lipid Peroxidation; Male; Mice, Inbred ICR; Mitochondria; Molecular Dynamics Simulation; Neutrophil Infiltration; Oxidative Stress; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2017 |